Liposomal Vector Mediated Delivery of the 3p FUS1 Gene Demonstrates Potent Antitumor Activity Against Human Lung Cancer in Vivo

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700756
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Enhancement of Antitumor Activity of Cisplatin in Human Lung Cancer Cells by Tumor Suppressor FUS1

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2007English

Connexin32-Mediated Antitumor Effects of Suicide Gene Therapy Against Hepatocellular Carcinoma: In Vitro and in Vivo Anticancer Activity

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Sorafenib Has Potent Antitumor Activity Against Multiple Myeloma in Vitro, Ex Vivo, and in Vivo in the 5T33MM Mouse Model

Cancer Research
Cancer ResearchOncology
2012English

Harnessing the Lysosome-Dependent Antitumor Activity of Phenothiazines in Human Small Cell Lung Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

Luliconazole Demonstrates Potent in Vitro Activity Against Dermatophytes Recovered From Patients With Onychomycosis

Journal of the American Academy of Dermatology
Dermatology
2014English

Antitumor Activity of Rhein Lysinate Against Human Glioma U87 Cells in Vitro and in Vivo

Oncology Reports
MedicineCancer ResearchOncology
2015English

Adenovirus-Mediated HCCS1 Overexpression Elicits a Potent Antitumor Efficacy on Human Colorectal Cancer and Hepatoma Cells Both in Vitro and in Vivo

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2008English

Targeted Adenoviral Vector Demonstrates Enhanced Efficacy for in Vivo Gene Therapy of Uterine Leiomyoma

Reproductive Sciences
GynecologyObstetrics
2016English

Local Delivery of IFNα Has Antitumor Activity in Bladder Cancer

Cancer Discovery
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy